A Republican bill with 7 Republican cosponsors · See all 7 cosponsors
Last activity — Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
In committee
Introduced and handed to a committee in the chamber it started in.
The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.
Its path through Congress
- Introduced
- In Committee
What this bill would do
This bill is called the Safeguarding Women from Chemical Abortion Act. It withdraws the approved application for the drug mifepristone for the purpose of terminating an intrauterine pregnancy within 14 days of the bill's enactment. It makes introducing the withdrawn drug into interstate commerce a violation of the Federal Food, Drug, and Cosmetic Act. The bill also considers the drug misbranded if its labeling states it can be used to terminate an intrauterine pregnancy. Additionally, it establishes a Federal tort allowing women to sue drug manufacturers for bodily injury or mental health harm caused by chemical abortion drugs. Finally, the bill states it does not affect certain existing federal laws related to mailing obscene or crime-inciting matter.
Yes
- Scored +5
Does this give the federal government more power?
The bill increases federal regulatory authority by withdrawing an FDA-approved drug via legislation and establishing a federal tort.
The opposite· 3 of 10
- Scored -10
Does this make abortion easier to get?
The bill withdraws approval for the abortion medication mifepristone and bans its distribution for terminating pregnancies.
- Scored -6
Would women be better off under this?
The bill bans a primary medication used for medical abortion, impacting women's healthcare access, though it creates a federal tort to sue manufacturers for harm.
- Scored -5
Does this narrow the gap between how men and women are treated?
The bill restricts bodily autonomy and healthcare options specific to women.
Who it would affect, and how
Potential Positive Impacts for People
- Section 3(b) and Section 3(c): Women who suffer bodily injury or mental health harm attributable to the use of a covered medication can bring a civil action against the manufacturer to seek compensatory damages, punitive damages, and attorney's fees and costs. This provides a legal avenue for individuals to hold manufacturers accountable.
Potential Negative Impacts for People
-
Section 2(1): The bill deems the approved application for the drug mifepristone for the termination of intrauterine pregnancy to be withdrawn 14 days after enactment, which removes access to this specific medication for that purpose.
-
Section 2(2): Introducing or delivering the withdrawn drug into interstate commerce is considered a violation of the Federal Food, Drug, and Cosmetic Act, making it illegal to distribute the drug for this use.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Tap or hover a score for the reason it gave.
- Demographic And Interest Groups
- Would women be better off under this? — The bill bans a primary medication used for medical abortion, impacting women's healthcare access, though it creates a federal tort to sue manufacturers for harm. Would business owners be better off under this? — Pharmaceutical manufacturers and distributors face new federal liabilities and marketing restrictions. Would people in their twenties and thirties be better off under this? — Young adults of reproductive age lose access to a common medical procedure and medication. Would households on low incomes be better off under this? — Low-income individuals may face greater difficulty in accessing alternative abortion care due to the ban on mifepristone. Would people in middle age be better off under this? — Individuals of reproductive age lose access to a specific medication.
- Healthcare
- Does this make abortion easier to get? — The bill withdraws approval for the abortion medication mifepristone and bans its distribution for terminating pregnancies. Does this make health care easier to get in general? — The bill restricts access to a specific pharmaceutical drug used for pregnancy termination.
- Social Issues And Justice
- Does this narrow the gap between how men and women are treated? — The bill restricts bodily autonomy and healthcare options specific to women.
- Governance And Ideology
- Does this give the federal government more power? — The bill increases federal regulatory authority by withdrawing an FDA-approved drug via legislation and establishing a federal tort. Does this protect people from being watched or searched? — The legislation limits individual medical privacy and personal healthcare choices. Does this make it easier to do business across state lines? — The bill places federal bans on the interstate transport and delivery of a specific medication.
- 6/23/2026
- 1 Cosponsor added.
- 4/20/2026
- 1 Cosponsor added.
- 4/15/2026
- 1 Cosponsor added.
- 3/25/2026
- 1 Cosponsor added.
- 3/23/2026
- 1 Cosponsor added.
- 3/18/2026
- 1 Cosponsor added.
- 3/12/2026
- 1 Cosponsor added.
- 3/11/2026
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Introduced in Senate
One bill Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.
Marsha BlackburnRepublican · Tennessee
Ted BuddRepublican · North Carolina
John CornynRepublican · Texas
James LankfordRepublican · Oklahoma
Bernie MorenoRepublican · Ohio
Mike RoundsRepublican · South Dakota
Tommy TubervilleRepublican · Alabama